Assist. Prof. Dr. Shinwoo Kang | Neuroinflammation | Best Researcher Award
Assist. Prof. Dr. Shinwoo Kang , Soonchunhyang, South Korea
Dr. Shinwoo Kang 🎓 is an Assistant Professor at Soonchunhyang University of Medicine 🏥 in Cheonan, South Korea. With a strong background in neuropharmacology and Alzheimer’s disease research 🧠, he completed his Ph.D. at Gachon University and later pursued postdoctoral studies at the Mayo Clinic in the U.S. 🇺🇸. Dr. Kang has authored numerous high-impact publications 📚 on alcohol-related neurodegeneration, neuroinflammation, and glial cell function. His multidisciplinary approach integrates oriental medicine and molecular neuroscience 🧬. Passionate about translational research, he continues to explore novel therapeutic strategies for neurodegenerative diseases 🌟 while mentoring future clinical scientists.
Professional Profile:
🏅 Summary of Suitability
Dr. Shinwoo Kang is highly suitable for the Best Researcher Award, based on his exceptional contributions to neuropharmacology and neurodegenerative disease research, particularly Alzheimer’s disease. His global research exposure, solid academic foundation, and innovative integration of oriental medicine with modern neuroscience make him a standout candidate.
📘 Education & Experience
🎓 Education
-
🧪 Ph.D. – Gachon University of Medicine and Science, Incheon, Korea (2017–2021)
-
🧬 M.S. – Gachon University of Medicine and Science, Incheon, Korea (2015–2017)
-
🌿 B.S. – Daegu Haany University, Daegu, Korea (2009–2015)
🧠 Research & Professional Experience
-
🧑🏫 Assistant Professor, Soonchunhyang University of Medicine (2024–Present)
-
🧪 Postdoctoral Fellow, Mayo Clinic College of Medicine and Science, MN, USA (2021–2024)
🚀 Professional Development
Dr. Kang has continuously enhanced his scientific and professional skills through international research fellowships 🌍, interdisciplinary collaborations 🔬, and certification programs 🎖️. He holds a certificate in Laboratory Animal Technology 🐭 and also trained in oriental medicine wholesale management 🌿. During his postdoctoral tenure at the Mayo Clinic, he gained cutting-edge expertise in neurodegeneration and translational neuroscience 🧠. He regularly participates in academic symposia and conferences 🎤, fostering knowledge exchange and innovation in clinical pharmacology and neuroscience. His dynamic development journey reflects a deep commitment to advancing neuropharmacological research and promoting academic excellence 📈.
🧪 Research Focus
Dr. Kang’s research is centered on neurodegenerative diseases, particularly Alzheimer’s disease 🧠, exploring the interplay between alcohol use disorder and neuroinflammation 🔥. His work delves into astrocyte function, synaptic stability, mitochondrial dysfunction, and glial regulation 🧬. He employs both molecular biology and behavioral models in his studies, aiming to uncover new therapeutic pathways for memory impairment and cognitive decline 💊. Dr. Kang is also interested in the effects of environmental and stress factors on brain health 🧠🌍. His interdisciplinary approach integrates traditional medicinbasic research with potential clinical applications 🧑⚕️.
🏅 Awards & Honors
-
🏆 Selected Presentation Award, Korean Society for Neurodegenerative Disease (KSND), Seoul (2019)
-
🖼️ Poster Presentation Award, Gachon University of Medicine and Science Symposium, Incheon (2015)
-
📜 Certificate of Laboratory Animal Technician (Serial No. 2930, 2015)
-
🌿 Oriental Medicine Wholesale Management Certificate (2015)
Publication Top Notes:
-
Title: Spatial memory deficiency early in 6xTg Alzheimer’s disease mouse model
Citations: 36 -
Title: The protective effects of PSM-04 against beta amyloid-induced neurotoxicity in primary cortical neurons and an animal model of Alzheimer’s disease
Citations: 34 -
Title: Metabotropic glutamate receptor 5 in amygdala target neurons regulates susceptibility to chronic social stress
Citations: 33 -
Title: Alcohol-induced neuroinflammatory response and mitochondrial dysfunction on aging and Alzheimer’s disease
Citations: 27 -
Title: Effects of a dehydroevodiamine-derivative on synaptic destabilization and memory impairment in the 5xFAD, Alzheimer’s disease mouse model
Citations: 27